Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis

Neurology

Volumn 38, Issue 2, 1988, Pages 258-261

  Hohlfeld, R ^a   Michels, M ^a   Heininger, K ^a   Besinger, U ^b   Toyka, K V ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHYLPREDNISOLONE;

FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AZATHIOPRINE; FEMALE; FOLLOW-UP STUDIES; HUMAN; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGE; MYASTHENIA GRAVIS; SUPPORT, NON-U.S. GOV'T;

EID: 0023845612     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.2.258     Document Type: Article

References (10)

1. Mertens HG, Hertel C, Reuther P, Ricker K. Effect of immunosup-pressive drugs (azathioprine). Ann NY Acad Sci 1981;377:691–699.
2. Witte AS, Cornblath DR, Parry GJ, Lieak RO, Schatz NJ. Azathioprine in the treatment of myasthenia gravis. Ann Neurol 1984;15:602–605.
3. Drachman DB. Myasthenia gravis: biology and treatment. Ann NY Acad Sci 1987;505:1–914.
4. Besinger UA, Toyka KV, Hemberg M, Heininger K, Hohlfeld R, Fateh-Moghadnm A. Myasthenia gravia: long-term correlation of binding and blocking antibadiea against acetylcholine receptors with changes in dieeaee severity. Neurology 1983;33:1316–1321
5. Hohlfeld R, Toyka KV, Beeinger U, Gerhold B, Heininger K. Myasthenia gravis: reactivation of clinical dieease and of autoimmune factors after discontinuation of long-term azathioprine. Ann Neurol 1985;17:238–242.
6. Kiseel JT, Levy RJ, Mendell JR, GriBge RC. Azathioprine toxicity in neuromwular disease. Neurology 1986;36:35–39.
7. McGrath BP, Ibele LS, Ftaii E, Hargrave M, Mahony JF, Stewart JH. Erythroid toxicity of azathioprine. Q J Med 1975;44:57–63.
8. Witte AS, Cornblath DR, Schatz NJ, Lkak RP. Monitoring azathioprine therapy in myasthenia gravis. Neurology 1986;36:533–1534.
9. Kinlen LJ, Sheil AGR, Peto J, Dou R. Collaborative United Kingdom—Australeeian study of cancer in patienta treated with immunosuppressive drugs. Br Med J 1979;2:1461–1466.
10. Lewia P, Hazleman BL, Hanka R, Roberta S. Cause of death in patients with rheumatoid arthritie with particular reference to azathioprine. Ann Rheum Die 1980;39:457–461.